A Study on Recombinant Botulinum Toxin Type A (YY001) for Injection in Multiple Treatments of Adult Upper Limb Spasticity

Recruiting

Phase 3 — Large-scale testing across thousands of people, comparing the new treatment against current standard treatments.

Trial locations(16 sites)

China

Peking Union Medical College Hospital, Beijing

West China Hospital，Sichuan University, Chengdu

Guangdong Provincial People's Hospital, Guangdong

Sun Yat-sen Memorial Hospital, Guangzhou

The Second People's Hospital of Hefei, Hefei

Huai'an First Hospital Affiliated to Nanjing Medical University, Huai'an

The First Affiliated Hospital of Henan University, Kaifeng

The Second Affiliated Hospital of Kunming Medical University, Kunming

Shanghai Fudan University HuaShan Hospital, Shanghai

Yangzhi Affiliated Rehabilitation Hospital of Tongji University, Shanghai

Shenzhen Second People's Hospital, Shenzhen

The First Affiliated Hospital of Soochow University, Suzhou

Shanxi Bethune Hospital, Taiyuan

Tianjin Medical University General Hospital, Tianjin

Xuzhou Medical University Affiliated Hospital, Xuzhou

Zibo Municipal Hospital, Zibo